Frailty States Research Articles

Investigating the prevalence of malnutrition, frailty and physical disability and the association between them amongst older care home residents

Malnutrition, frailty and physical disability are inter-related, more prevalent in the older population and increase the risk of adverse health outcomes. Thus, screening is essential, especially in the understudied care home setting where the population is vulnerable and at higher risk of malnutrition. Furthermore, prevalence may vary depending upon screening tools used. The aims of this study were to: 1) investigate the prevalence of 1) malnutrition risk using Mini Nutritional Assessment - Short Form (MNA-SF) and Malnutrition Universal Screening Tool (MUST), 2) frailty using the Edmonton Frailty Scale (EFS), 3) physical disability using the Barthel Index (BI) and (4) examine the association between variables and coexistence of states. Screening for malnutrition (MNA-SF and MUST) and frailty (EFS) was performed as part of a comprehensive geriatric assessment (CGA) in 527 residents from 17 care homes in Lincoln, UK. Mean age of the group was 85.6±7.6 years and body mass index, BMI 23.0±5.1kg/m2. A high prevalence of malnutrition risk was detected: 41.4% by MNA-SF and 25.5% by MUST (high risk/malnourished). Furthermore, there was a clear discordance between MNA-SF and MUST scoring of malnutrition; for example, the percentage of those identified as being at low risk was 18.8% using the MNA-SF and 57.0% using the MUST. In addition, there was a high prevalence of severe frailty by EFS (69.6%) and functional impairment by BI (62.0%). There was good association between some variables (P<0.001) and 33.4% of residents had coexistence of all three states of malnutrition, frailty and physical disability. Malnutrition risk, frailty and physical disability are highly prevalent in care home residents and interrelated. However, prevalence varies depending on the screening tool used. More research should be conducted in the care home setting to improve daily clinical practice as screening may impact upon subsequent treatment and care modalities and clinical outcomes.

Relationship of Vitamin D status with testosterone levels: a systematic review and meta-analysis.

Despite a biological plausibility of a direct link between low vitamin D and androgen deficiency, the association remains inconclusive in epidemiological studies. Therefore, this systematic review and meta-analysis of case-control studies aim to assess whether and in what populations such an association can be demonstrated. A systematic search was performed in PubMed, EMBASE, Cochrane Library, Web of science, Science Direct, and CINAHL. Standardized mean differences (SMDs) and 95% confidence intervals (CIs) in total testosterone (TT) levels between men with 25-hydroxyvitamin D (25(OH)D) <20 and ≥20 ng/mL were combined using random-effects models. Funnel plot and trim-and-fill analysis were used to assess publication bias. Heterogeneity source was explored by a sub-group analysis according to health-related characteristics of the study populations. Eighteen included studies collectively gave information on 9892 men with vitamin D deficiency and 10,675 controls. The pooled SMD revealed a slight, albeit just significant, positive association between 25(OH)D and TT (pooled SMD: -0.23, 95% CI: -0.45 to -0.01; P = 0.04) with a large between-study heterogeneity (I2 = 98%, Pfor heterogeneity < 0.00001). At the sub-group analysis, a significant positive association, along with noticeable decrease in heterogeneity, could only be demonstrated in studies of patients with frailty states (pooled SMD: -0.19; 95% CI: -0.27, -0.10, P < 0.0001; I2 = 51%, Pfor heterogeneity = 0.06). A sensitivity analysis revealed a high stability of the result and the trim-and-fill adjustment for publication bias did not affect pooled estimate. Both hypovitaminosis D and androgen deficiency should be regarded as markers of a poor health status, sharing common underlying aetiologies and risk factors.

Factors associated with short term transitions in frailty status in the population ≥ 50 years of age

Abstract Background Frailty is a clinical state that increases an individual's vulnerability and leads to chronic and complex medical needs in the older population. Transition to frailty is a dynamic and reversible process. Therefore, identification of determinants of transitions between frailty states is important for preventive action. This study assesses correlates of short time transitions in frailty states in the non-institutionalized population aged ≥ 50 years in Belgium. Methods 404 respondents of the Belgian health interview survey 2018 belonging to the target age group participated in a subsequent health examination survey (average time lapse 53 days). At both time points frailty was assessed with the SHARE frailty instrument classifying respondents as robust, prefrail or frail according to Fried's phenotype. Physical, biomedical, mental, social and demographic determinants of transitions in frailty status were explored through relative risk ratios (RRR) from a backward stepwise multinomial regression analysis. Results Both upward and downward transitions occurred in 21% of the respondents. Transitions were more frequent in women. Being obese (RRR 1.93; 95%CI 1.02-3.67) and being unsatisfied with social contacts (RRR 4.35; 95%CI 1.59-11.86) were significantly associated with a transition to a less favorable frailty status. Activity limitations (RRR 0.30; 95%CI 0.13-0.68) and a high serum total/HDL-cholesterol ratio (RRR 0.19; 95%CI 0.04-0.79) were inversely associated with an improvement of the frailty status. No significant associations were found with age, education level, multimorbidity, mental health, quality of life, smoking, physical activity, hyperglycemia, hypertension and increased C-reactive protein. Conclusions Preventive action to delay or reverse the transition towards frailty should start from 50 years onwards and include nutritional advise, actions that facilitate people to participate in activities and initiatives to improve social networks of people. Key messages Obesity and a high serum total/HDL-cholesterol ratio are risk factors for developing frailty. Investing in a good social network and an environment which facilitates participation in activities is important to delay or reverse the evolution towards frailty.

178. Minimally invasive surgery mitigates but does not eliminate adverse perioperative outcomes for frail TLIF

BACKGROUND CONTEXT Frailty is an increasingly recognized characteristic that has been validated across many studies as influencing operative risk. Utilization of frailty indices can allow for its identification of which spine patients may be too high risk for surgical intervention. This may be especially useful when it comes to surgeries that are minimally invasive and are supposed to have decrease perioperative outcomes. PURPOSE Identify MIS techniques effects in postoperative outcomes in TLIF patients. STUDY DESIGN/SETTING Retrospective review of a prospective database. PATIENT SAMPLE TLIF spine patients. OUTCOME MEASURES Complications, length of stay (LOS), estimated blood loss (EBL). METHODS Pts that underwent a lumbar spine procedure in a single-center Comprehensive Spine Quality Database. Pts were stratified based on procedural approach (Open [OP] and Minimally invasive Surgery [MIS]). Frailty was then calculated for each resultant group by using 30 variables with a validated method. Based on these scores, pts were categorized no frailty [NF]: 0.18. Groups were then controlled for surgical invasiveness. Chi-squared tests identified the relationship between complications and length of stay among various frailty states given surgical approach (OP vs MIS). These patients were propensity score matched for levels fused. Hospital acquired complications (HACs) were identified based on frailty groups through the use of chi-squared and t-tests for other surgical factors. A logistic regression analysis identified the association between frailty status and surgical, regarding postoperative (postop) outcomes. RESULTS A total of 1,300 TLIF spine patients were isolated (59yrs, 29.3kg/m2). After PSM for levels fused, there were 338 pts for both MIS and OP. MIS pts were older (56.1 vs 53.3; p CONCLUSIONS This study displays that when frailty status is taken into account, TLIF MIS patients benefit from this procedure type when analyzed against neurologic complications. However, these patients were seen to suffer more from postop complications but did not differ on any other specific complications or surgical variables. FDA DEVICE/DRUG STATUS This abstract does not discuss or include any applicable devices or drugs.

256. Does patient frailty status influence recovery patterns and ultimate outcome following spinal fusion for cervical deformity?

BACKGROUND CONTEXT Frailty has been utilized in cervical deformity (CD) to characterize the influence of preop health state on postop outcomes. Frailty severity may be an important determinant for impaired recovery after CD corrective surgery. No prior studies have examined the associations between increasingly frail states and the trajectory of recovery in CD realignment. PURPOSE Evaluate postop clinical recovery among CD patients between frailty states undergoing primary procedures STUDY DESIGN/SETTING Retrospective review of a prospective CD database PATIENT SAMPLE A total of 106 CD patients. OUTCOME MEASURES Baseline (BL) to 1-Year(1Y) HRQL Instruments: NDI, mJOA, EQ5D METHODS Patients>18yrs undergoing surgery for CD (C2-7 Cobb>10°, coronal Cobb>10°, cSVA>4cm or TS-CL>10°, or CBVA>25°) with HRQL data at BL, 3M and 1Y postop intervals were identified. Patients were stratified by the modified CD frailty index (mCD-FI, Passias et al.) scale from 0-1 (no frailty: 0.3[F]). Patients in NF and F groups were propensity score matched (PSM) for TS-CL to control for baseline deformity. Demographics, alignment and Ames-ISSG deformity modifiers were assessed using chi-squared and paired t-tests to compare HRQL outcomes. HRQL outcomes were normalized by dividing BL and postop (3M, 1Y) outcomes by BL for each patient. Normalized scores (y-axis) were plotted against duration of follow-up (x-axis). AUC was calculated for follow-up time intervals; total area for each follow-up interval was divided by cumulative follow-up, determining overall normalized, time-adjusted HRQL outcomes (Integrated Health State [IHS]). IHS was compared between NF and F groups. RESULTS A total of 106 CD patients included (61.7yrs, 66% F, 27.7kg/m2). By frailty group: 52.8% NF, 47.2% F. After PSM for TS-CL (mean: 38.1°), 38 patients remained in each of the NF and F groups. By surgical approach, 46.1% underwent posterior approach, 19.7% anterior, and 34.2% combined; which was not significant between the frailty groups(p>0.05). At baseline, cervical and spinopelvic radiographic parameters were not significant, except for the C7-S1 SVA (NF: -26.5mm vs F: 15.2mm, p=0.007). According to BL HRQLs, F patients displayed significantly worse NDI scores (NF: 36.8 F: 55.4; p 0.05). F patients had more postop major complications (31.3%) compared to the NF (8.9%), p=0.004, though DJK occurrence and reoperation between the groups was not significant. CONCLUSIONS While all groups exhibited improved postop disability/pain scores, frail patients recovered better in overall health state. Despite frail patients having more complications, they seem to have overall better patient-reported outcomes, signifying that with frailty severity, patients have more room for improvement postop compared to baseline quality of life. FDA DEVICE/DRUG STATUS This abstract does not discuss or include any applicable devices or drugs.

A cost utility analysis of treating different adult spinal deformity frailty states

The aim of this study was to investigate the cost utility of treating non-frail versus frail or severely frail adult spinal deformity (ASD) patients. 79 surgical ASD patients >18 years with available frailty and ODI data at baseline and 2-years post-surgery (2Y) were included. Utility data was calculated using the ODI converted to the SF-6D. QALYs utilized a 3% discount rate to account for decline to life expectancy (LE). Costs were calculated using the PearlDiver database. ICER was compared between non-operative (non-op.) and operative (op.) NF and F/SF patients at 2Y and LE. When compared to non-operative ASD, the ICER was $447,943.96 vs. $313,211.01 for NF and F/SF at 2Y, and $68,311.35 vs. $47,764.61 for NF and F/SF at LE. Frail and severely frail patients had lower cost per QALY compared to not frail patients at 2Y and life expectancy, and had lower ICER values when compared to a non-operative cohort of ASD patients. While these results support operative correction of frail and severely frail patients, it is important to note that these patients are often at worse baseline disability, which is closely related to frailty scores, and have more opportunity to improve postoperatively. Furthermore, there may be a threshold of frailty that is not operable due to the risk of severe complications that is not captured by this analysis. While future research should investigate economic outcomes at extended follow up times, these findings support the cost effectiveness of ASD surgery at all frailty states.

Factors Associated With Improving or Worsening the State of Frailty: A Secondary Data Analysis of a 5-Year Longitudinal Study.

This study aims to examine the frailty transition patterns of older adults recruited from both community and residential care settings within a 5-year period, and to identify the physical and psychosocial factors associated with the transitions. This study is a secondary data analysis of a longitudinal study for tracking the change of health status of older adults 60 years of age or older. Participants who had undergone at least two assessments during 2013-2017 were selected for analysis. Guided by the Gobben's Frailty Model, biopsychosocial predictors were comprehensively identified from the literature, and their relationship to frailty state transition was explored. We compared the baseline characteristics of participants at the frail, pre-frail, and robust states (categorized using the Fried Frailty Index). A generalized estimating equation was used to identify factors associated with an improvement or a deterioration in frailty. The probability of transitions between frailty states was calculated. Among the 306 participants, 19% (n = 59) improved and 30% (n = 92) declined in frailty within the project period. Sleep difficulties (odds ratio [OR] = 1.76; 95% confidence interval [CI]: 1.07-2.90; p = .027), better cognitive status (OR = 0.80-0.84; 95% CI: 0.66-0.98 and 0.73-2.73; p = .031 and .018), good nutritional status (OR = 0.74; 95% CI: 0.59-0.91; p = .005), slow mobility (OR = 1.03-1.13; 95% CI: 1.00-1.05 and 1.03-1.25; p = .047 and .014), hearing impairment (OR = 2.83; 95% CI: 1.00-8.01; p = .05), better quality of health-physical domain (OR = 0.95; 95% CI: 0.92-0.99; p = .006), and better functional ability (OR = 0.85-0.97; 95% CI: 0.79-0.92 and 0.96-0.99; p < .001 and p = .003) were significant associated factors in the worsening group. More physical activity (OR = 1.01; 95% CI: 1.00-1.01 and 1.01-1.02; p = .026 and p < .001), hearing impairment (OR = 0.26; 95% CI: 0.08-0.86; p = .028), and slow mobility (OR = 0.93; 95% CI: 0.87-1.00; p = .037) were significant associated factors in the improvement group. Frailty is a crucial global public health issue. This study provides evidence for nurses to holistically consider the associated factors and to design effective interventions to combat frailty in our ageing society. Frailty is a transient state that can be reversed. Professional nurses working in both community and residential care settings should be able to identify older adults at risk and improve their health conditions appropriately.

Transitions between frailty states in the very old: the influence of socioeconomic status and multi-morbidity in the Newcastle 85+ cohort study.

BackgroundUsing Newcastle 85+ Study data, we investigated transitions between frailty states from age 85 to 90 years and whether multi-morbidities and socioeconomic status (SES) modify transitions.MethodsThe Newcastle 85+ Study is a prospective, longitudinal cohort study of all people born in 1921 in Newcastle and North Tyneside. Data included: a multidimensional health assessment; general practice record review (GPRR) and date of death. Using the Fried phenotype (participants defined as robust, pre-frail or frail), frailty was measured at baseline, 18, 36 and 60 months.ResultsFrailty scores were available for 82% (696/845) of participants at baseline. The prevalence of frailty was higher in women (29.7%, 123/414) than men (17.7%, 50/282) at baseline and all subsequent time points. Of those robust at baseline, 44.6% (50/112) remained robust at 18 months and 28% (14/50) at age 90. Most (52%) remained in the same state across consecutive interviews; only 6% of the transitions were recovery (from pre-frail to robust or frail to pre-frail), and none were from frail to robust. Four or more diseases inferred a greater likelihood of progression from robust to pre-frail even after adjustment for SES. SES did not influence the likelihood of moving from one frailty state to another.ConclusionsAlmost half the time between age 85 and 90, on average, was spent in a pre-frail state; multi-morbidity increased the chance of progression from robust and to frail; greater clinical intervention at the onset of a first chronic illness, to prevent transition to multi-morbidity, should be encouraged.

Korean frailty and aging cohort study (KFACS): cohort profile

PurposeThe purpose of the Korean Frailty and Aging Cohort Study (KFACS) is to initiate a nationwide, population-based prospective cohort study of older adults living in the community to assess their...

Pre-frailty factors in community-dwelling 40\u201375\u2009year olds: opportunities for successful ageing

BackgroundThere is little known about pre-frailty attributes or when changes which contribute to frailty might be detectable and amenable to change. This study explores pre-frailty and frailty in independent community-dwelling adults aged 40–75 years.MethodsParticipants were recruited through local council networks, a national bank and one university in Adelaide, Australia. Fried frailty phenotype scores were calculated from measures of unintentional weight loss, exhaustion, low physical activity levels, poor hand grip strength and slow walking speed. Participants were identified as not frail (no phenotypes), pre-frail (one or two phenotypes) or frail (three or more phenotypes). Factor analysis was applied to binary forms of 25 published frailty measures Differences were tested in mean factor scores between the three Fried frailty phenotypes and ROC curves estimated predictive capacity of factors.ResultsOf 656 participants (67% female; mean age 59.9 years, SD 10.6) 59.2% were classified as not frail, 39.0% pre-frail and 1.8% frail. There were no gender or age differences. Seven frailty factors were identified, incorporating all 25 frailty measures. Factors 1 and 7 significantly predicted progression from not-frail to pre-frail (Factor 1 AUC 0.64 (95%CI 0.60–0.68, combined dynamic trunk stability and lower limb functional strength, balance, foot sensation, hearing, lean muscle mass and low BMI; Factor 7 AUC 0.55 (95%CI 0.52–0.59) comprising continence and nutrition. Factors 3 and 4 significantly predicted progression from pre-frail to frail (Factor 3 AUC 0.65 (95% CI 0.59–0.70)), combining living alone, sleep quality, depression and anxiety, and lung function; Factor 4 AUC 0.60 (95%CI 0.54–0.66) comprising perceived exertion on exercise, and falls history.ConclusionsThis research identified pre-frailty and frailty states in people aged in their 40s and 50s. Pre-frailty in body systems performance can be detected by a range of mutable measures, and interventions to prevent progression to frailty could be commenced from the fourth decade of life.

Does Patient Frailty Status Influence Recovery Following Spinal Fusion for Adult Spinal Deformity?: An Analysis of Patients With 3-Year Follow-up.

Retrospective review of a prospective database. The aim of this study was to evaluate postop clinical recovery among adult spinal deformity (ASD) patients between frailty states undergoing primary procedures SUMMARY OF BACKGROUND DATA.: Frailty severity may be an important determinant for impaired recovery after corrective surgery. It included ASD patients with health-related quality of life (HRQLs) at baseline (BL), 1 year (1Y), and 3 years (3Y). Patients stratified by frailty by ASD-frailty index scale 0-1(no frailty: <0.3 [NF], mild: 0.3-0.5 [MF], severe: >0.5 [SF]). Demographics, alignment, and SRS-Schwab modifiers were assessed with χ/paired t tests to compare HRQLs: Scoliosis Research Society 22-question Questionnaire (SRS-22), Numeric Rating Scale (NRS) Back/Leg Pain, Oswestry Disability Index (ODI). Area-under-the-curve (AUC) method generated normalized HRQL scores at baseline (BL) and f/u intervals (1Y, 3Y). AUC was calculated for each f/u, and total area was divided by cumulative f/u, generating one number describing recovery (Integrated Health State [IHS]). A total of 191 patients were included (59 years, 80% females). Breakdown of patients by frailty status: 43.6% NF, 40.8% MF, 15.6% SF. SF patients were older (P = 0.003), >body mass index (P = 0.002). MF and SF were significantly (P < 0.001) more malaligned at BL: pelvic tilt (NF: 21.6°; MF: 27.3°; SF: 22.1°), pelvic incidence and lumbar lordosis (7.4°, 21.2°, 19.7°), sagittal vertical axis (31 mm, 87 mm, 82 mm). By SRS-Schwab, NF were mostly minor (40%), and MF and SF markedly deformed (64%, 57%). Frailty groups exhibited BL to 3Y improvement in SRS-22, ODI, NRS Back/Leg (P < 0.001). After HRQL normalization, SF had improvement in SRS-22 at year 1 and year 3 (P < 0.001), and NRS Back at 1Y. 3Y IHS showed a significant difference in SRS-22 (NF: 1.2 vs. MF: 1.32 vs. SF: 1.69, P < 0.001) and NRS Back Pain (NF: 0.52, MF: 0.66, SF: 0.6, P = 0.025) between frailty groups. SF had more complications (79%). SF/marked deformity had larger invasiveness score (112) compared to MF/moderate deformity (86.2). Controlling for baseline deformity and invasiveness, SF showed more improvement in SRS-22 IHS (NF: 1.21, MF: 1.32, SF: 1.66, P < 0.001). Although all frailty groups exhibited improved postop disability/pain scores, SF patients recovered better in SRS-22 and NRS Back. Despite SF patients having more complications and larger invasiveness scores, they had overall better patient-reported outcomes, signifying that with frailty severity, patients have more room for improvement postop compared to BL quality of life. 3.

Protein intake and transitions between frailty states and to death in very old adults: the Newcastle 85+ study.

ObjectivesTo examine the association of protein intake with frailty progression in very old adults.DesignThe Newcastle 85+ study, a prospective longitudinal study of people aged 85 years old in Northeast England and followed over 5 years.Setting and Participants668 community-dwelling older adults (59% women) at baseline, with complete dietary assessment and Fried frailty status (FFS).MeasuresDietary intake was estimated with 2 × 24-h multiple pass recalls at baseline. FFS was based on five criteria: shrinking, physical endurance/energy, low physical activity, weakness and slow walking speed and was available at baseline and 1.5, 3 and 5 years. The contribution of protein intake (g/kg adjusted body weight/day [g/kg aBW/d]) to transitions to and from FFS (robust, pre-frail and frail) and to death over 5 years was examined by multi-state models.ResultsIncrease in one unit of protein intake (g/kg aBW/d) decreased the likelihood of transitioning from pre-frail to frail after adjusting for age, sex, education and multimorbidity (hazard ratios [HR]: 0.44, 95% confidence interval [CI]: 0.25–0.77) but not for the other transitions. Reductions in incident frailty were equally present in individuals with protein intake ≥0.8 (HR: 0.60, 95% CI: 0.43–0.84) and ≥1 g/kg aBW/d (HR: 0.63, 95% CI: 0.44–0.90) from 85 to 90 years. This relationship was attenuated after adjustment for energy intake, but the direction of the association remained the same (e.g. g/kg aBW/d model: HR: 0.71, 95% CI: 0.36–1.41).ConclusionHigh protein intake, partly mediated by energy intake, may delay incident frailty in very old adults. Frailty prevention strategies in this age group should consider adequate provision of protein and energy.

The Co-Occurrence Of Frailty (Accumulation Of Functional Deficits) And Depressive Symptoms, And Its Effect On Mortality In Older Adults: A Longitudinal Study.

PurposeThe co-occurrence of frailty and depression in late life, the possibility for symptom reversal, their reciprocal relationship, and the effects on mortality have rarely been investigated. We aimed to examine the co-occurrence of frailty and depressive symptoms in late life, the possibility for symptom reversal, their reciprocal relationship, and the effects on mortality using all the information from a longitudinal study.Patients and methodsWe used the Taiwan Longitudinal Study of Aging (TLSA) for this study. TLSA was initiated in 1989 and followed periodically. We included participants from 1989 to 2007, who had data on frailty and depressive symptoms. Frailty was assessed by accumulation of functional deficits in 6 dimensions including disease status, sensory dysfunction, balance, functional limitations, health risk behaviors, and life satisfaction. Depressive symptoms were measured with the Center for Epidemiologic Studies Depression Scale (CES-D). A multistate model with interval censoring was used to examine the transition between states of frailty with or without depressive symptoms, and finally to death. A mixed model was used to examine the relationships between frailty and depressive symptoms.ResultsThe coexistence of frailty and depressive symptoms was associated with higher mortality. Individuals with depressive symptom had a lower probability of reversal to a better state. Previous depression score predicted current frailty, but the coefficient was smaller than that of previous frailty. Previous frailty predicted current depression score, and the coefficient was stronger than that of previous depression.ConclusionDepressive symptoms increased the mortality and decreased the probability of reversal in the frail older adults.

65. A risk/benefit analysis of increasing surgical invasiveness relative to frailty status in adult spinal deformity surgery

BACKGROUND CONTEXT The Adult Spinal Deformity Invasiveness Index incorporates deformity-specific components to assess the magnitude of correction. It's unknown how invasiveness relates to outcomes in each frailty state. PURPOSE Investigate the relationship between increasing invasiveness and outcomes in adult spinal deformity (ASD) surgery in each frailty states. STUDY DESIGN/SETTING Retrospective review of prospective, consecutively enrolled multicenter ASD database. PATIENT SAMPLE One hundred ninety-five ASD patients with baseline demographic and surgical details. OUTCOME MEASURES Invasiveness, frailty, minimal clinically important differences (MCID) for the Oswestry Disability Index, SF-36 Physical Component Scores, and Scoliosis Research Society Scores. METHODS ASD patients (scoliosis ≥20°, SVA ≥5cm, PT ≥25°, or TK ≥60°) with baseline frailty and invasiveness scores. Invasiveness index included: posterior: decompression (1), fusion (2), instrumentation (1); osteotomies: 3-coloumn (14), Ponte (1), interbody fusion: anterior lumbar (8), transforaminal/posterior lumbar (2), iliac fixation (2), revision surgery (3). Invasiveness scores were calculated within different frailty states (not frail, NF, 0.5). Logistic regression analysis assessed the relationship between increasing invasiveness and major complications or reoperations and meeting MCID for any of the measured HRQLs at 3 years. Decision tree analysis assessed thresholds for an invasiveness risk benefit cutoff point, above which experiencing complications or reoperations and not reaching MCID were higher. Significance was set to p RESULTS Of the 322 patients, 195 met inclusion criteria. Baseline demographic info: age 59.9±14.4, 75% female, BMI 27.8±6.2, CCI 1.7±1.7. Baseline surgical info: 61% osteotomy, 52% decompression, 11.0±4.1 levels fused. There were 98 NF, 65 F, and 30 SF patients. For the entire cohort, binary regression analysis found a significant relationship between increasing invasiveness and experiencing a major complication or reoperation (1.01[1.00-1.02], p=0.01). Within each frailty subgroup, the results were 1.01([1.00-1.03], p=0.05) for NF, 1.01([1.01-1.02], p CONCLUSIONS Increasing invasiveness is associated with increased odds of major complications and reoperations. A risk/benefit cutoff for decreasing major complications/reoperations and meeting MCID was found to be 79.3 for NF patients, 111 for F patients, and 53.3 for SF patients. Above these thresholds, increasing invasiveness is associated with increasing the risk of major complications or reoperations and not meeting MCID at 3 years. FDA DEVICE/DRUG STATUS This abstract does not discuss or include any applicable devices or drugs.

49. Increasing surgical invasiveness relative to frailty status in cervical deformity surgery: a risk benefit analysis

BACKGROUND CONTEXT The Adult Spinal Deformity Invasiveness Index incorporates deformity-specific components to assess the magnitude of correction. It's unknown how invasiveness relates to outcomes in each frailty state. PURPOSE Investigate the relationship between increasing invasiveness and outcomes in ASD surgery in each frailty states. STUDY DESIGN/SETTING Retrospective review of prospective, consecutively enrolled multicenter ASD database. PATIENT SAMPLE A total of 195 ASD patients with baseline demographic and surgical details. OUTCOME MEASURES Invasiveness, frailty, minimal clinically important differences (MCID) for the Oswestry Disability Index, SF-36 Physical Component Scores, and Scoliosis Research Society Scores. METHODS ASD patients (scoliosis ≥20°, SVA ≥5cm, PT ≥25°, or TK ≥60°) with baseline frailty and invasiveness scores. Invasiveness index included; posterior: decompression (1), fusion (2), instrumentation (1), osteotomies: 3-coloumn (14), Ponte (1), interbody fusion; anterior lumbar (8), transforaminal/posterior lumbar (2), iliac fixation (2), revision surgery (3). Invasiveness scores were calculated within different frailty states (not frail, NF, 0.5). Logistic regression analysis assessed the relationship between increasing invasiveness and major complications or reoperations and meeting MCID for any of the measured HRQLs at 3 years. Decision tree analysis assessed thresholds for an invasiveness risk benefit cutoff point, above which experiencing complications or reoperations and not reaching MCID were higher. Significance was set to p RESULTS One hundred ninety-five of 322 patients met inclusion criteria. Baseline demographic info: age 59.9 ± 14.4, 75% female, BMI 27.8 ± 6.2, CCI 1.7 ± 1.7. Baseline surgical info: 61% osteotomy, 52% decompression, 11.0 ± 4.1 levels fused. There were 98 NF, 65 F, and 30 SF patients. For the entire cohort, binary regression analysis found a significant relationship between increasing invasiveness and experiencing a major complication or reoperation (1.01 [1.00-1.02], p=0.01). Within each frailty subgroup, the results were 1.01 ([1.00-1.03], p=0.05) for NF, 1.01 ([1.01-1.02], p CONCLUSIONS Increasing invasiveness is associated with increased odds of major complications and reoperations. A risk/benefit cutoff for decreasing major complications/reoperations and meeting MCID was found to be 79.3 for NF patients, 111 for F patients, and 53.3 for SF patients. Above these thresholds, increasing invasiveness is associated with increasing the risk of major complications or reoperations and not meeting MCID at 3 years. FDA DEVICE/DRUG STATUS This abstract does not discuss or include any applicable devices or drugs.

P70. Frailty does not negatively impact cost utility in adult spinal deformity

BACKGROUND CONTEXT The Adult Spinal Deformity Frailty Index (ASD-FI), a validated modality for quantifying frailty, stratifies patients into categories not frail (NF), frail (F) and severely frail (SF). However, the cost of treating each frailty state is unknown. PURPOSE Investigate the cost utility of treating not frail versus frail or severely frail ASD patients. STUDY DESIGN/SETTING Retrospective review of a prospective single center adult spinal deformity database. PATIENT SAMPLE A total of 79 operative and non operative ASD patients ≥18 years old, with baseline and 2Y ASD-FI and Oswestry Disability Index (ODI) scores. OUTCOME MEASURES ODI, SF-6D, Cost per quality adjusted life years (QALY), Incremental Cost Effectiveness, Ratio (ICER). METHODS Inclusion criteria was surgical ASD (scoliosis≥20°, SVA≥5cm, PT≥25°, or thoracic kyphosis ≥60°) patients >18 years with available frailty and ODI data at BL and 2-years post op. Independent T-Tests assessed baseline radiographic differences in PT, PI-LL, and Schwab SVA modifier status between NF vs. F/SF patients. Utility data was calculated using the ODI converted to the SF-6D using published conversion methods. QALYs utilized a 3% discount rate to account for residual decline to life expectancy (78.7 years). Costs were calculated using the PearlDiver database. After accounting for complications, LOS, revisions, and death, cost per QALY at 2Y and life expectancy were calculated for NF, and F/SF patients. ICER was compared between non op and operative NF and F/SF patients at 2Y and life expectancy. RESULTS Seventy-nine ASD patients met inclusion criteria. Descriptive statistics for the cohort were: age 51.0±6.8, 76% women, BMI 26.7±6.8, 54% osteotomy, 54% decompression, and 11.6±4.2 average levels fused. At BL, there were 48 NF, 26 F, and 4 SF pts. The average BL frailty for NF pts was 0.13±0.08, 0.39±0.06 for F, and 0.59±0.08 for SF pts. There were no differences in PT, PI-LL, or severe SVA Schwab modifier grades between NF or F/SF pts (all p>0.05). At 2-year follow up, there was no difference in the average cost of ASD surgery, $91,068.98 for NF patients and $90,888.53 for F/SF pts (p>0.05). The cost per QALY was higher for NF pts at 2 years vs F/SF pts ($464,239.62 vs. $321,107.89, p CONCLUSIONS Frail and severely frail patients had lower cost per QALY compared to not frail patients at 3 years and life expectancy. In addition, when compared to a non operative cohort of ASD patients, frail and severely frail patients had lower ICER values. While these results support operative correction of frail and severely frail patients, it is important to note that these patients are often at worse baseline disability, which is closely related to frailty scores, and have more opportunity to improve postoperatively. In addition, there may be a threshold of frailty that is not operable due to the risk of severe complications that is not captured by this analysis. While future research should investigate economic outcomes at extended follow-up times, these findings support the cost effectiveness of ASD surgery at all frailty states. FDA DEVICE/DRUG STATUS This abstract does not discuss or include any applicable devices or drugs.

Phase angle and metabolic equivalents as predictors of frailty transitions in advanced age.

The aim of this prospective study was to investigate whether two cellular and metabolic health indices, phase angle (PhA) and metabolic equivalents (METs), can predict changes in frailty states in fit community-dwelling older people. A sample of 118 individuals aged ≥65 years who attended a twice-weekly mild fitness program of aerobic and/or resistance exercises was enrolled in the study. At baseline and after three years, individuals underwent a clinical examination, biochemical determinations, bioelectrical impedance analysis, body composition assessment with dual energy X-ray absorptiometry, physical performance tests, and frailty and sarcopenia assessment. In 78 participants was executed indirect calorimetry, too. Based on frailty transitions during the follow-up between non-frailty, pre-frailty and frailty, participants were categorized as improved, stable (non-frail or pre-frail), and worsened or remaining frail. The chances to experience different frailty changes by baseline PhA and METs were explored through multinomial regression analysis and expressed as odds ratios (OR) and 95% Confidence intervals (95%CI). During the follow-up, 8 participants improved in frailty status, 84 were stable and 26 worsened or remained frail. For each one-unit increase in PhA, the odds of improving in frailty increased by 4.53 times (95%CI:1.18-17.46); while for each one-unit increase in METs, the odds of worsening in frailty decreased by 65% (95%CI:0.16-0.79). PhA and METs may be indirect measures of functional reserve, with lower values being potential biomarkers of evolving frailty.

Factors associated with changes of the frailty status after age 70: Findings in the MAPT study

PurposeFrailty has become a major issue in the prevention of functional decline and disability in aged populations. Using repeated measurements of frailty over 3 years, this work aimed to describe transitions between frailty states and associated factors. MethodsThis study used the data from the Multidomain Alzheimer Preventive Trial and included the 842 participants aged 70 and over who did not receive the multidomain intervention. Frailty was assessed using the phenotype proposed by Fried et al. at baseline and at 6, 12, 24, and 36 months. Factors influencing the transitions across frailty states were examined using multistate modeling. ResultsThe study population included 548 women and 294 men, mean age 75.4 ± 4.5 years. At baseline, 430 (53%) participants were nonfrail, 349 (43%) prefrail, and 28 (4%) frail. A total of 2271 pairs of consecutive measurements of frailty status were available over the 3 years of follow-up, with no change in frailty status in 1548 of them (68%), a worsening of frailty status in 426 of them (19%), and an improvement in frailty status in the remaining 297 (13%). Polypharmacy (i.e., ≥6 drugs) and probable depression were associated with incident prefrailty. Female gender was systematically associated with a lower probability of recovering from prefrailty and frailty. Older age, overweight, comorbidity, and abnormal C-reactive protein also reduced the probability of recovery from frailty or prefrailty. ConclusionsThis study sheds light on factors that should be further investigated in future research to help the prevention and management of frailty.

Frailty trajectories in adult lung transplantation: A cohort study

Frailty is common in adults with advanced lung disease and is associated with death before and after lung transplantation. We aimed to determine whether frailty changes from before to after the lung transplant. In a single-center, prospective cohort study among adults undergoing lung transplantation from 2010 to 2017, we assessed frailty by the Short Physical Performance Battery (SPPB; higher scores reflect less frailty) and Fried Frailty Phenotype (FFP; higher scores reflect greater frailty) before and repeatedly up to 36 months after transplant. We tested for changes in frailty scores over time using segmented mixed effects models, adjusting for age, sex, and diagnosis. We quantified the proportion of subjects transitioning between frailty states (frail vs not frail) from before to after the transplant. In 246 subjects, changes in frailty occurred within the first 6 post-operative months and remained stable thereafter. The overall change in frailty was attributable to improvements among those subjects who were frail before transplant. They experienced a 5.1-point improvement in SPPB (95% confidence interval [CI] 4.6-5.7) and a 1.8-point improvement in FFP (95% CI -2.1 to -1.6) during the early period. Frailty by SPPB and FFP did not change in those who were not frail before transplant. Approximately 84% of survivors who were frail before transplant became not frail after transplant. Pre-operative frailty resolves in many patients after lung transplantation. Because a large proportion of frailty may be attributable to advanced lung disease, frailty alone should not be an absolute contraindication to transplantation.

Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysis.

To investigate: (1) the cross-sectional association between polypharmacy, hyperpolypharmacy and presence of prefrailty or frailty; (2) the risk of incident prefrailty or frailty in persons with polypharmacy, and vice versa. A systematic review and meta-analysis was performed according to PRISMA guidelines. We searched PubMed, Web of Science, and Embase from 01/01/1998 to 5/2/2018. Pooled estimates were obtained through random effect models and Mantel-Haenszel weighting. Homogeneity was assessed with the I2 statistic and publication bias with Egger's and Begg's tests. Thirty-seven studies were included. The pooled proportion of polypharmacy in persons with prefrailty and frailty was 47% (95% CI 33-61) and 59% (95% CI 42-76), respectively. Increased odds ratio of polypharmacy were seen for prefrail (pooled OR = 1.52; 95% CI 1.32-1.79) and frail persons (pooled OR = 2.62, 95% CI 1.81-3.79). Hyperpolypharmacy was also increased in prefrail (OR = 1.95; 95% CI 1.41-2.70) and frail (OR = 6.57; 95% CI 9.57-10.48) persons compared to robust persons. Only seven longitudinal studies reported data on the risk of either incident prefrailty or frailty in persons with baseline polypharmacy. A significant higher odds of developing prefrailty was found in robust persons with polypharmacy (pooled OR = 1.30; 95% CI 1.12-1.51). We found no papers investigating polypharmacy incidence in persons with prefrailty/frailty. Polypharmacy is common in prefrail and frail persons, and these individuals are also more likely to be on extreme drug regimens, i.e. hyperpolypharmacy, than robust older persons. More research is needed to investigate the causal relationship between polypharmacy and frailty syndromes, thereby identifying ways to jointly reduce drug burden and prefrailty/frailty in these individuals. CRD42018104756.